NCT05935189 Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens
| NCT ID | NCT05935189 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nikomed Medical Center |
| Condition | Hepatocellular Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-07-01 |
| Primary Completion | 2028-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-07-01 with a primary completion date of 2028-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the study is to establish a cancer registry to facilitate research and assist in the identification of additional risk factors for hepatocellular carcinoma. The main objectives are: 1. provide a mechanism to store the information about subjects with hepatocellular carcinoma 2. use of tissue samples for translational/further research purposes
Eligibility Criteria
Inclusion Criteria: * Patients with biopsy-confirmed diagnosis of HCC * Armenian descent * Having given their signed Informed consent Exclusion Criteria: * Failure to obtain informed consent
Contact & Investigator
Hasmik Ghazinian, MD
PRINCIPAL INVESTIGATOR
Nikomed Medical Center
Frequently Asked Questions
Who can join the NCT05935189 clinical trial?
This trial is open to participants of all sexes, studying Hepatocellular Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05935189 currently recruiting?
Yes, NCT05935189 is actively recruiting participants. Contact the research team at tigran1999@yahoo.com for enrollment information.
Where is the NCT05935189 trial being conducted?
This trial is being conducted at Yerevan, Armenia.
Who is sponsoring the NCT05935189 clinical trial?
NCT05935189 is sponsored by Nikomed Medical Center. The principal investigator is Hasmik Ghazinian, MD at Nikomed Medical Center. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.